This prospective study will assess Ozurdex in the treatment of Diabetic Macular Oedema in clinical practice.
Study Type
OBSERVATIONAL
Enrollment
202
Ozurdex® treatment for diabetic macular oedema as per standard of care in clinical practice.
Retina and Macula Specialists,Hurstville
Hurtsville, New South Wales, Australia
Mean change in Best Corrected Visual Acuity (BCVA) from baseline
Time frame: Baseline, Month 12
Mean change in Central Retinal Thickness (CRT) from baseline
Time frame: Baseline, Month 12
Percentage of patients with a BCVA improvement of 15 letters or more
Time frame: Baseline, Month 12
Percentage of patients with a BCVA improvement of 10 letters or more
Time frame: Baseline, Month 12
BCVA average mean from baseline in area under the curve (AUC) analysis
Time frame: Baseline, Month 12
Number of Intraocular Pressure (IOP)-lowering treatments used to control IOP increase
Time frame: 12 Months
Mean BCVA at each injection number
Time frame: 12 Months
Mean change from baseline in BCVA at each injection number
Time frame: Baseline, Month 12
Mean change in BCVA across all the study injection numbers
Time frame: Baseline, 12 Months
Percentage of patients with BCVA improvement
Time frame: Baseline, Month 12
Percentage of BCVA losers
Time frame: Baseline, Month 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Retina Associates
Liverpool, New South Wales, Australia
Retina and Macula Specialists, Miranda
Miranda, New South Wales, Australia
Eye Doctors Mona Vale
Mona Vale, New South Wales, Australia
Marsden Eye Clinic
Parramatta, New South Wales, Australia
Retina & Vitreous Centre Strathfield
Strathfield, New South Wales, Australia
Strathfield Retina
Strathfield, New South Wales, Australia
Retina & Vitreous Centre City
Sydney, New South Wales, Australia
Sydney Eye and Retina Clinic
Sydney, New South Wales, Australia
Sydney Eye Hospital/Macular Diseases Centre
Sydney, New South Wales, Australia
...and 13 more locations
Percentage of patients improving to 20/40 or better
Time frame: Month 12
Mean number of Ozurdex injections
Time frame: 12 Months
Mean interval between Ozurdex® injections
Time frame: 12 Months
Change from baseline in central subfield retinal thickness by Optical Coherence Tomography (OCT) before each follow-up injection number
Time frame: Baseline, Month 12